This page is no longer being maintained. Please visit our new site at http://attcnetwork.org.

Ya no se mantiene esta página. Por favor visite nuestro nuevo sitio en http://attcnetwork.org.

MAT for Opioid Use Disorders
Northwest ATTC (2012-2017)

Event Type: Educational Event
What: Course Overview Harmful opioid use, including heroin, oxycodone and hydrocodone, and opioid use disorders remain a critical national public health concern. There are several FDA-approved medications to assist in the treatment of opioid use disorders and each of these medications offers individuals a somewhat different approach. This training will focus on enhancing understanding of the role of methadone, buprenorphine, and oral and extended-release naltrexone in treating opioid use disorders. The training will provide an overview of the research related to the use of these medications for both adults and young adults, as well as the practical issues related to providing coordinated care for individuals utilizing these medications as a treatment intervention. This training will also provide information about the use of the naloxone (Narcan) in the treatment of opioid overdose and as an overdose prevention tool.
When: 9/6/2017;  8:30 AM To 12:30 PM
Where: Oxford Suites- Bellingham
4051 Meridian Street
Bellingham, Washington 98226
For more information, contact: Anya Ludwig - NWATTC
Phone: 5034948255
Fax:
Email: ludwig@ohsu.edu
Registration: Go to https://www3.thedatabank.com/dpg/423/mtglistproc.asp?formid=nwmeet&caleventid=32000
Collaborators:
Washington Department of Social and Health Services/Division of Behavioral Health and Recovery
Attachments:
  • 9.6 MAT OUD flyer

    NOTE: To view Adobe Acrobat files, you must have a copy of Adobe Reader. You can download it for free.

  • ATTC Network Home      Treatment & Help      The ATTC Hub        Contact Us      Site Map      Copyright Information      Join Our Email List